New Microchip Sensor Measures Stress Hormones from Drop of Blood

Translate to Spanish or other 102 languages!

A depiction of stress molecules in blood electronically being detected inside nano-wells. By Ella Marushchenko

Mega Doctor News

- Advertisement -

Newswise — New Brunswick, N.J. – A Rutgers-led team of researchers has developed a microchip that can measure stress hormones in real time from a drop of blood. 

The study appears in the journal Science Advances

Cortisol and other stress hormones regulate many aspects of our physical and mental health, including sleep quality. High levels of cortisol can result in poor sleep, which increases stress that can contribute to panic attacks, heart attacks and other ailments. 

- Advertisement -

Currently, measuring cortisol takes costly and cumbersome laboratory setups, so the Rutgers-led team looked for a way to monitor its natural fluctuations in daily life and provide patients with feedback that allows them to receive the right treatment at the right time. 

The researchers used the same technologies used to fabricate computer chips to build sensors thinner than a human hair that can detect biomolecules at low levels. They validated the miniaturized device’s performance on 65 blood samples from patients with rheumatoid arthritis. 

“The use of nanosensors allowed us to detect cortisol molecules directly without the need for any other molecules or particles to act as labels,” said lead author Reza Mahmoodi, a postdoctoral scholar in the Department of Electrical and Computer Engineering at Rutgers University-New Brunswick. 

With technologies like the team’s new microchip, patients can monitor their hormone levels and better manage chronic inflammation, stress and other conditions at a lower cost, said senior author Mehdi Javanmard, an associate professor in Rutgers’ Department of Electrical and Computer Engineering. 

- Advertisement -

“Our new sensor produces an accurate and reliable response that allows a continuous readout of cortisol levels for real-time analysis,” he added. “It has great potential to be adapted to non-invasive cortisol measurement in other fluids such as saliva and urine. The fact that molecular labels are not required eliminates the need for large bulky instruments like optical microscopes and plate readers, making the readout instrumentation something you can measure ultimately in a small pocket-sized box or even fit onto a wristband one day.”  The study included Rutgers co-author Pengfei Xie, a Ph.D. student, and researchers from the University of Minnesota and University of Pennsylvania. The research was funded by the DARPA ElectRX program.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

DHR Health Continues to Lead the Way in Treatment of Alzheimer’s Disease for the RGV

Two years after DHR Health announced it was the first hospital south of San Antonio to successfully administer Leqembi, an FDA-approved intravenous treatment for early Alzheimer’s disease, DHR Health continues to expand access to advanced Alzheimer’s care for patients in the Rio Grande Valley being now the only facility doing amyloid PET Scans, a diagnostic test to accurately diagnose Alzheimer’s disease. DHR Health also offers Kisunla, another FDA-approved intravenous treatment for early symptomatic Alzheimer’s disease.

STHS Edinburg Teams Up with Reserva Coffee Roasters for Premium Patient Experience

With the grand opening of Reserva Coffee Roasters’ newest café, the warmth and comfort of home are now just a brew away at South Texas Health System Edinburg (STHS) and STHS Children’s, helping create the perfect setting for connection, conversation and community for hospital visitors, staff and physicians.

McAllen Mayor Leads Public Push for Early Lung Cancer Detection

McAllen Mayor Javier Villalobos hosted a televised discussion on lung cancer awareness with pulmonologist Juan P. Rey Mendoza and retired McAllen Police Lieutenant Joel Morales to encourage Rio Grande Valley residents to seek screening and recognize the risks of delayed diagnosis.

Pharr Goes Purple: City Proclaims June 2026 as Alzheimer’s & Brain Awareness Month

The Pharr City Commission proclaimed June 2026 as Alzheimer’s & Brain Awareness Month, recognizing the millions of individuals, families, caregivers, and researchers affected by Alzheimer’s disease and other forms of dementia.
- Advertisement -